Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

February 4, 2019

Belimumab Maintenance Fails to Delay Relapse in AAV Patients, Phase 3 Trial Suggests

News

A combination of belimumab plus standard maintenance treatment is no better than standard of care alone at delaying relapse in ANCA-associated vasculitis (AAV) patients in remission, a Phase 3 clinical trial shows. ... Read more

January 22, 2019

Mycophenolate Mofetil Can Replace Cyclophosphamide at Inducing Remission in Some AAV Patients, Clinical Trial Suggests

News

The immunosuppressant agent mycophenolate mofetil (MMF) is similar to standard cyclophosphamide at inducing remission in ANCA-associated vasculitis (AAV) patients, but it seems to be associated with a higher relapse ... Read more

November 29, 2018

Early Disease Status Predicts Long-term Outcomes in AAV Patients, Study Suggests

News

Disease status at three and six months seems to predict long-term survival and kidney failure in patients with ANCA-associated vasculitis (AAV), a study shows. These findings suggest that early disease ... Read more

October 23, 2018

FDA Expands Approval of Rituxan as Remission Maintenance Treatment for GPA and MPA Patients

News

The U.S. Food and Drug Administration has approved a label update for Rituxan (rituximab) to include information for patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) who ... Read more

October 1, 2018

Small-vessel Vasculitides Linked to Worse Prognosis During ICU Stays, Polish Study Finds

News

Patients with small-vessel vasculitides, including ANCA-associated vasculitis, are more likely to need aggressive treatments or to die in the intensive care unit (ICU) than patients with other systemic autoimmune diseases, ... Read more

September 25, 2018

Low C3 Levels at Diagnosis Can Predict Severity of ANCA-associated Vasculitis, Poor Kidney Outcomes, Study Finds

News

Patients with ANCA-associated vasculitis (AAV) are more likely to exhibit severe disease and experience poor kidney outcomes if they have low levels of the C3 complement protein at diagnosis, ... Read more

Pin It on Pinterest